HomeNewsIndiaCOVID-19 | Delhi to give compensation up to Rs 5 lakh for deaths due to oxygen shortage, forms panel to assess cases

COVID-19 | Delhi to give compensation up to Rs 5 lakh for deaths due to oxygen shortage, forms panel to assess cases

Delhi COVID Deaths: The committee will assess online and offline complaints and/or representations regarding deaths due to oxygen shortage on “case-to-case basis”

May 28, 2021 / 11:17 IST
Story continues below Advertisement
Workers stand as a tank is filled with liquid oxygen at a hospital, amid the spread of COVID-19 in New Delhi on April 22, 2021. (Image: Reuters/Adnan Abidi)
Workers stand as a tank is filled with liquid oxygen at a hospital, amid the spread of COVID-19 in New Delhi on April 22, 2021. (Image: Reuters/Adnan Abidi)

Delhi has decided to give compensation of up to Rs 5 lakh each, for COVID-19 patients who died due to oxygen shortage in the city amid the harsh second wave of coronavirus in India.

The state government has thus constituted a six-member committee to assess cases and “check whether the oxygen was being used properly at the hospital as per the norms,” as per the official order issued on May 27.

Story continues below Advertisement

"The committee would draw up an objective criteria to award compensation, limited to a maximum of Rs 5 lakh in each case," it added.

Follow our LIVE blog on the COVID-19 pandemic here

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show